Mabel Ventures Inc. (CSE:MBL)
Canada · Delayed Price · Currency is CAD 0.0600
0.00 (0.00%)
At close: Jun 26, 2025
CTI BioPharma Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.55M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2024 | - | - | - |
| Aug 31, 2023 | - | - | - |
| Aug 31, 2022 | - | - | - |
| Aug 31, 2021 | - | - | - |
| Aug 31, 2020 | - | - | - |
| Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Royal Bank of Canada | 58.14B |
| The Toronto-Dominion Bank | 62.22B |
| Enbridge | 64.48B |
| Brookfield Asset Management | 5.93B |
| Brookfield | 106.76B |
| Bank of Montreal | 30.60B |
| Thomson Reuters | 9.98B |
| Constellation Software | 14.65B |